Vascular Anomaly Pathology and Genomics Biopsy Study

Arteriovenous Malformations Clinical Trial

Official title: Validation of Core Biopsy of Vascular Anomalies for Clinical Pathology and Genomics

Status Completed

Clinical Trial Summary

The purpose of this research is to gather information on the safety and effectiveness of core biopsy of vascular anomalies for clinical pathology and clinical genomics studies.

Clinical Trial Description

Vascular anomalies or vascular malformations often are treated with minimally invasive sclerotherapy, embolization or ablation based on clinical and imaging features without acquisition of tissue. Over the last two decades there have been significant advancements in the understanding of the genetic basis for various vascular anomalies/malformations, which may guide use of therapies for individualized treatment.

As such, given the emergence of novel medications for treatment of vascular anomalies/malformations based on genetic information, acquisition of tissue for pathology and genomic characterization will be increasingly important as treatment of vascular anomalies/vascular malformations moves toward individualized medicine approach. ;

Related Conditions & MeSH terms

• Arteriovenous Malformations
• Congenital Abnormalities
• Hemangioma
• Klippel Trenaunay Syndrome
• Lymphangioma
• Lymphatic Abnormalities
• Lymphatic Malformation
• Vascular Anomaly
• Vascular Malformations
• Venous Malformation

• NCT number: NCT04836884
• Study type: Interventional
• Source: Mayo Clinic
• Status: Completed
• Phase: N/A
• Start date: April 6, 2021
• Completion date: January 31, 2022